SCHEMBL13894880

SCHEMBL13894880

Cn1c(N2CCC(C(N)=O)CC2)nc2cc(-c3ccc(-c4ccc(Cl)cc4)cn3)ccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ AHR P35869 1/20 0.45
▸ SMN1; SMN2 Q16637 5/20 0.44
▸ RAB9A P51151 4/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ MCHR1 Q99705 2/20 0.43
▸ MTOR P42345 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ DGAT1 O75907 2/20 0.40
▸ KCNH2 Q12809 2/20 0.40
▸ GAK O14976 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ NEK2 P51955 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13895019 0.88 MCHR1 (0.43) MCHR1MTORL3MBTL1DGAT1KCNH2
SCHEMBL13894788 0.86 MCHR1 (0.43) RAB9AMCHR1MTORDGAT1KCNH2
SCHEMBL13895117 0.85 MCHR1 (0.49) SMN1; SMN2RAB9ANPC1MCHR1MTOR
SCHEMBL13887396 0.84 MCHR1 (0.60) GAAHTTAHRSMN1; SMN2RAB9A
SCHEMBL13894953 0.84 MCHR1 (0.44) MCHR1HTR6CYP3A4
SCHEMBL13894787 0.84 MCHR1 (0.51) GAAHTTSMN1; SMN2RAB9ANPC1
SCHEMBL13894952 0.83 MCHR1 (0.42) MCHR1MTORDGAT1KCNH2
SCHEMBL13894933 0.83 MCHR1 (0.42) MCHR1MTORL3MBTL1DGAT1KCNH2
SCHEMBL13894951 0.82 MCHR1 (0.41) MCHR1MTORMAPTDGAT1KCNH2
SCHEMBL13895113 0.82 ALDH1A1 (0.44) GAASMN1; SMN2RAB9ANPC1MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524862-B2 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-28 — — US disclosed
Send feedback